Ms. Gallagher joined Astrocyte Pharmaceuticals’ Board of Directors in November 2021, bringing over 30 years of experience as an investment banker focused on the life sciences industry. She is currently Founder and CEO of Alkamont Advisors, a boutique providing independent capital markets and strategic advice to small and mid-stage healthcare companies. Previously, she was Managing Director, Equity Capital Markets at Truist Securities (formerly SunTrust Robinson Humphrey) where she was directly responsible for leading the planning, structuring and execution of equity capital raises for public and private companies. Ms. Gallagher has been an advisor to numerous boards and management teams on a wide range of corporate finance solutions and her healthcare investment banking experience includes the execution of over 300 M&A, advisory and financing transactions raising over $35 billion of capital and advisory work valued at over $20 billion.
Prior to joining Truist, Ms. Gallagher was the Head of the Life Sciences Investment Banking team at BMO Capital Markets, a Partner and Head of Healthcare at C.E. Unterberg, Towbin, and served in a variety of roles over many years at JP Morgan and predecessor firms including Managing Director, Healthcare Group and Head of Healthcare M&A. Ms. Gallagher received her M.B.A. in Finance from New York University’s Stern School of Business and a B.A. in Biology from Colgate University. She is a trustee emeritus at Colgate University.
